Cross-domain Fisher criterion for remote therapeutic efficacy assessment of Parkinson's disease via speech recognition

Comput Methods Biomech Biomed Engin. 2025 Dec 15:1-14. doi: 10.1080/10255842.2025.2601318. Online ahead of print.

Abstract

To address the limitation that prevailing cross-domain Parkinson's disease (PD) speech recognition methods mitigate small-sample issues via distribution matching while disregarding substantial feature overlap, we introduce the cross-domain Fisher criterion (CFC). CFC reformulates inter- and intra-class scatter matrices to align with classifier properties: the former enhances separation among heterogeneous target-domain samples, whereas the latter compactly aggregates homologous cross-domain samples around the target centroid and suppresses inter-domain disparities. Numerous experimental results demonstrate that CFC is an effective, efficient, and robust method for PD speech recognition, offering a promising approach for integration into PD speech-based remote rehabilitation and monitoring systems..

Keywords: Cross-domain Fisher criterion; Parkinson’s disease; remote therapeutic efficacy assessment; speech recognition.